The Role of Concurrent Chemotherapy in Patients With Stage IVC Nasopharyngeal Carcinoma Treated With Palliative Chemotherapy Followed by Definitive Radiation Therapy to Primary Tumor
Mei Lan(Sichuan Cancer Hospital), Tai Xiang Lu(Sun Yat-sen University), San‐Gang Wu(First Affiliated Hospital of Xiamen University), Jyh‐Fei Liao(National Yang Ming Chiao Tung University), Ting Xu(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(Thoracic Surgery Foundation), C. Chen(Sun Yat-sen University), Fei Han(Sun Yat-sen University), Li Tian(Sun Yat-sen University), Li-Sheng Zheng(State Key Laboratory of Oncology in South China), Zhijun Duan(Dalian Medical University)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2016
Cited by 0
Related Papers
A three-dimensional model of the yeast genome
|Nature|2010|1.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
|Radiotherapy and Oncology|2017|374